Introduction
Duchenne Muscular Dystrophy - Overview
Duchenne Muscular Dystrophy - Therapeutics Development
Duchenne Muscular Dystrophy - Therapeutics Assessment
Duchenne Muscular Dystrophy - Companies Involved in Therapeutics Development
Duchenne Muscular Dystrophy - Drug Profiles
Duchenne Muscular Dystrophy - Dormant Projects
Duchenne Muscular Dystrophy - Discontinued Products
Duchenne Muscular Dystrophy - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Duchenne Muscular Dystrophy, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Products under Development by Companies, H1 2020 (Contd..4), H1 2020
Products under Development by Companies, H1 2020 (Contd..5), H1 2020
Products under Development by Companies, H1 2020 (Contd..6), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Duchenne Muscular Dystrophy - Pipeline by 4D Molecular Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by AAVogen Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Akashi Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Alpha Anomeric, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Anagenesis Biotechnologies SAS, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Antisense Therapeutics Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Armgo Pharma Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Audentes Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by AUM LifeTech Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Avidity Biosciences LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Axolo Pharma Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Beech Tree Labs Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Biogen Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by BioIncept LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Bioleaders Corp, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Biophytis SA, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Capricor Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Catabasis Pharmaceuticals Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Consortium.AI, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Constant Therapeutics LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by CRISPR Therapeutics AG, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Cumberland Pharmaceuticals Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Daiichi Sankyo Co Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by DepYmed Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by DMD Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by DTx Pharma Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Dyne Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Dystrogen Therapeutics SA, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Edgewise Therapeutics, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Editas Medicine Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Eloxx Pharmaceuticals Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Epirium Bio Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Evox Therapeutics Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by FibroGen Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by FibroGenesis LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Fulcrum Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Galapagos NV, H1 2020
Duchenne Muscular Dystrophy - Pipeline by GlaxoSmithKline Plc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Hibernaid Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by InnoBioscience LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Italfarmaco SpA, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Ixchel Pharma LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Keros Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by LambdaGen Therapeutics, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Milo Biotechnology LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Mitobridge Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Mitochon Pharmaceuticals Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by MyoGene Bio LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Myos Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by MyoTherix Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by NicOx SA, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Nippon Shinyaku Co Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Novartis AG, H1 2020
Duchenne Muscular Dystrophy - Pipeline by NS Pharma Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by OliPass Corporation, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Oncotelic Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Pepgen Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by PeptiDream Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Pfizer Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by PhaseBio Pharmaceuticals Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Progenitor Therapeutics Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Prothelia Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by PTC Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by RASRx LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by ReveraGen BioPharma Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Ridgeline Therapeutics LLC, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Santhera Pharmaceuticals Holding AG, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Sarcomed AB, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Sarepta Therapeutics Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Solid Biosciences Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by SOM Biotech SL, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Sutura Therapeutics Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Taiho Pharmaceutical Co Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Teijin Pharma Ltd, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Tivorsan Pharmaceuticals Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Tolerion Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Vertex Pharmaceuticals Inc, H1 2020
Duchenne Muscular Dystrophy - Pipeline by Zata Pharmaceuticals Inc, H1 2020
Duchenne Muscular Dystrophy - Dormant Projects, H1 2020
Duchenne Muscular Dystrophy - Dormant Projects, H1 2020 (Contd..1), H1 2020
Duchenne Muscular Dystrophy - Dormant Projects, H1 2020 (Contd..2), H1 2020
Duchenne Muscular Dystrophy - Dormant Projects, H1 2020 (Contd..3), H1 2020
Duchenne Muscular Dystrophy - Dormant Projects, H1 2020 (Contd..4), H1 2020
Duchenne Muscular Dystrophy - Discontinued Products, H1 2020
Duchenne Muscular Dystrophy - Discontinued Products, H1 2020 (Contd..1), H1 2020

List of Figures
Number of Products under Development for Duchenne Muscular Dystrophy, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• 4D Molecular Therapeutics Inc
• AAVogen Inc
• Akashi Therapeutics Inc
• Alpha Anomeric
• Anagenesis Biotechnologies SAS
• Antisense Therapeutics Ltd
• Armgo Pharma Inc
• Audentes Therapeutics Inc
• AUM LifeTech Inc
• Avidity Biosciences LLC
• Axolo Pharma Inc
• Beech Tree Labs Inc
• Biogen Inc
• BioIncept LLC
• Bioleaders Corp
• Biophytis SA
• Capricor Therapeutics Inc
• Catabasis Pharmaceuticals Inc
• Consortium.AI
• Constant Therapeutics LLC
• CRISPR Therapeutics AG
• Cumberland Pharmaceuticals Inc
• Daiichi Sankyo Co Ltd
• DepYmed Inc
• DMD Therapeutics Inc
• DTx Pharma Inc
• Dyne Therapeutics Inc
• Dystrogen Therapeutics SA
• Edgewise Therapeutics
• Editas Medicine Inc
• Eloxx Pharmaceuticals Inc
• Epirium Bio Inc
• Evox Therapeutics Ltd
• FibroGen Inc
• FibroGenesis LLC
• Fulcrum Therapeutics Inc
• Galapagos NV
• GlaxoSmithKline Plc
• Hibernaid Inc
• InnoBioscience LLC
• Italfarmaco SpA
• Ixchel Pharma LLC
• Keros Therapeutics Inc
• LambdaGen Therapeutics
• Milo Biotechnology LLC
• Mitobridge Inc
• Mitochon Pharmaceuticals Inc
• MyoGene Bio LLC
• Myos Inc
• MyoTherix Inc
• NicOx SA
• Nippon Shinyaku Co Ltd
• Novartis AG
• NS Pharma Inc
• OliPass Corporation
• Oncotelic Inc
• Pepgen Ltd
• PeptiDream Inc
• Pfizer Inc
• PhaseBio Pharmaceuticals Inc
• Progenitor Therapeutics Ltd
• Prothelia Inc
• PTC Therapeutics Inc
• RASRx LLC
• ReveraGen BioPharma Inc
• Ridgeline Therapeutics LLC
• Santhera Pharmaceuticals Holding AG
• Sarcomed AB
• Sarepta Therapeutics Inc
• Solid Biosciences Inc
• SOM Biotech SL
• Sutura Therapeutics Ltd
• Taiho Pharmaceutical Co Ltd
• Teijin Pharma Ltd
• Tivorsan Pharmaceuticals Inc
• Tolerion Inc
• Vertex Pharmaceuticals Inc
• Zata Pharmaceuticals Inc